Press Releases Abbott Laboratories

Equities

ABT

US0028241000

Market Closed - Nyse Other stock markets 04:00:01 2024-06-07 pm EDT			5-day change	1st Jan Change
107.6 ^USD	+3.17%		+5.27%	-2.26%

May. 30	U.S. FDA set to reorganize its food division starting October	RE
May. 30	Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abbott Laboratories : Receives CE Mark for AVEIR™ DR, the World's First Dual Chamber Leadless Pacemaker System	Jun. 06	PU
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients	Jun. 03	PR
Understanding Product-By-Process Claims In Patent Law	May. 14	AQ
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX	May. 01	AQ
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee	Apr. 29	PR
Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range	Apr. 17	AQ
Abbott: Q1 Earnings Snapshot	Apr. 17	AQ
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges	Apr. 17	PR
Practical Lessons From NCS Multistage Inc v. Kobold Corporation	Apr. 12	AQ
ABBOTT RECEIVES FDA APPROVAL FOR TRICLIP, FIRST-OF-ITS-KIND DEVICE TO REPAIR LEAKY TRICUSPID HEART VALVE	Apr. 03	AQ
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve	Apr. 02	PR
Abbott Hosts Conference Call for First-Quarter Earnings	Mar. 27	PR
Abbott Laboratories : Receives CE Mark for its Groundbreaking Assert-IQ™ Insertable Cardiac Monitor, Expanding Availability of Long-Term Monitoring for Irregular Heart Rhythms	Mar. 25	PU
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	Mar. 20	AQ
Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System	Mar. 19	AQ
ABBOTT - REAL-WORLD DATA SHOW ABBOTT'S FREESTYLE LIBRE SYSTEMS AND GLP-1 MEDICINES WORK BETTER TOGETHER FOR PEOPLE WITH TYPE 2 DIABETES	Mar. 07	AQ
Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes	Mar. 06	PR
A brain pacemaker helped a woman with crippling depression. It may soon be available to more people	Feb. 21	AQ
Medical Technology Stocks to Keep on The Radar (ORHB, MDT, BSX, ABT)	Feb. 20	AQ
Medical Technology Stocks to Keep On The Radar	Feb. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Abbott Laboratories

Equities

ABT

US0028241000

Press Releases

Filters